Medtronic Plc [MDT] stock is trading at $101.2, up 1.86%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The MDT shares have gain 5.56% over the last week, with a monthly amount glided 7.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medtronic Plc [NYSE: MDT] stock has seen the most recent analyst activity on November 19, 2025, when Goldman upgraded its rating to a Neutral but kept the price target unchanged to $111 for it. Previously, Wolfe Research upgraded its rating to Peer Perform on June 30, 2025. On June 16, 2025, Leerink Partners initiated with an Outperform rating and assigned a price target of $110 on the stock. Citigroup upgraded its rating to a Buy and increased its price target to $107 on March 04, 2025. RBC Capital Mkts upgraded its rating to an Outperform and raised its price target to $105 on October 10, 2024. Oppenheimer reiterated a Perform rating for this stock on August 21, 2024, and upped its price target to $94. In a note dated August 15, 2024, UBS upgraded a Neutral rating on this stock and boosted its target price from $76 to $90.
Medtronic Plc [MDT] stock has fluctuated between $79.29 and $102.59 over the past year. Currently, Wall Street analysts expect the stock to reach $111.5 within the next 12 months. Medtronic Plc [NYSE: MDT] shares were valued at $101.2 at the most recent close of the market. An investor can expect a potential return of 10.18% based on the average MDT price forecast.
Analyzing the MDT fundamentals
Medtronic Plc [NYSE:MDT] reported sales of 34.76B for the trailing twelve months, which represents a growth of 6.64%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at 0.18%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 10.76, Equity is 0.13 and Total Capital is -6.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.63 points at the first support level, and at 98.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 102.40, and for the 2nd resistance point, it is at 103.60.
Ratios To Look Out For
For context, Medtronic Plc’s Current Ratio is 2.01. Also, the Quick Ratio is 1.50, while the Cash Ratio stands at 1.44. Considering the valuation of this stock, the price to sales ratio is 3.73, the price to book ratio is 2.71 and price to earnings (TTM) ratio is 27.32.
Transactions by insiders
Recent insider trading involved Smith Gregory L, EVP Global Ops & Supply Chain, that happened on Nov 19 ’25 when 30000.0 shares were sold. Officer, Smith Gregory L completed a deal on Nov 19 ’25 to buy 30000.0 shares. Meanwhile, EVP & President Cardiovascular KIIL HARRY SKIP sold 8605.0 shares on Sep 03 ’25.
